| Codeifai Limited (CDE) ORDINARY FULLY PAID |
Industrials |
$8 |
CDE signs Tracer deal with A$130,000 minimum year 1 revenue
|
27 Feb 2025 8:47AM |
$0.001 |
$0.010 |
risen by
900%
|
|
CDE - Price-sensitive ASX Announcement
Full Release
Key Points
- CDE signs a three-year contract with minimum revenue of A$130,000 in year 1.
- Contract includes 'take or pay' provisions and a minimum order quantity of 600,000 RMB.
- CDE gains exclusivity in the chemical fibre industry in China for the contract term.
- Projected revenues for year 2 are 2.25 million RMB and for year 3 are 3.25 million RMB.
- The customer is Hangzhou Carbon-Oxygen Power Tech Co., Ltd., part of Transfar Group.
- Contract valued at RMB6.1 million over three years, approximately A$1.33 million.
- This is the highest value contract for CDE's Tracer technology signed to date.
- CDE's technology will enhance brand protection for globally renowned textile products.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Aussie Broadband Limited (ABB) ORDINARY FULLY PAID |
Communication Services |
$1,276 |
Update - Notification of buy-back - ABB
|
27 Feb 2025 8:46AM |
$3.870 |
$4.360 |
risen by
12.66%
|
|
| AMCIL Limited (AMH) ORDINARY FULLY PAID |
Financials |
$311 |
Update - Notification of buy-back - AMH
|
27 Feb 2025 8:45AM |
$1.150 |
$0.985 |
fallen by
14.35%
|
|
| Butn Limited (BTN) ORDINARY FULLY PAID |
Financials |
$16 |
Butn launches franchise funding with Jim's Group
|
27 Feb 2025 8:44AM |
$0.115 |
$0.041 |
fallen by
64.35%
|
|
BTN - Price-sensitive ASX Announcement
Full Release
Key Points
- Butn Ltd launches 'Franchise Funding' product in association with Jim's Group.
- The joint venture aims to support over 100 new franchisees each month at an average cost of $30,000.
- Butn's funding will enable new franchisees to start earning money immediately.
- The JV will combine Butn's funding expertise with Jim's Group's franchising knowledge.
- Joint marketing and distribution activities will be conducted by both companies.
- The JV is on track for a Q3 FY2025 launch in Australia, with plans for expansion into New Zealand.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Dusk Group Limited (DSK) ORDINARY FULLY PAID |
Consumer Discretionary |
$52 |
Dividend/Distribution - DSK
|
27 Feb 2025 8:43AM |
$1.220 |
$0.840 |
fallen by
31.15%
|
|
| Antilles Gold Limited (AAU) ORDINARY FULLY PAID |
Materials |
$37 |
Application for quotation of securities - AAU
|
27 Feb 2025 8:43AM |
$0.005 |
$0.012 |
risen by
140%
|
|
| SenSen Networks Limited (SNS) ORDINARY FULLY PAID |
Information Technology |
$40 |
FY25 Half Year Results Presentation
|
27 Feb 2025 8:43AM |
$0.036 |
$0.048 |
risen by
33.33%
|
|
SNS - Price-sensitive ASX Announcement
Full Release
Key Points
- Record first half cash receipts of $6.3M, up 3.6% over PCP
- Transitioned from net debt of ($0.7M) to net cash of $0.6M
- Underlying Earnings improved $0.5M over PCP to ($0.1M)
- Total expenses reduced by $0.5M (7%) over H1 FY24
- North America now accounts for 26% of revenue, up from 21% in H1 FY24
- Secured significant contracts in Calgary, Montreal, and Toronto
- New product development underway to expand kerb monitoring solutions
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Novatti Group Limited (NOV) ORDINARY FULLY PAID |
Information Technology |
$16 |
H1 FY25 Results Announcement
|
27 Feb 2025 8:43AM |
$0.032 |
$0.027 |
fallen by
15.63%
|
|
NOV - Price-sensitive ASX Announcement
Full Release
Key Points
- $26.2m in H1 revenue – up 22.3% YoY
- 29% decrease in H1 FY25 opex YoY
- 97% YoY improvement in H1 EBITDA to ($0.36m)
- 2024 cost out program fully implemented – full benefits from H2 FY25
- Business streamlined with sale of International Bank of Australia interest for $2.87m
- Balance sheet strengthened with removal of legacy liabilities and capital raising
- Remain on track to achieve positive operating cashflow for the half-year ending June 2025
- $6.25m cash at end of H1 FY25
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Goodman Group (GMG) FULLY PAID ORDINARY/UNITS STAPLED SECURITIES |
Real Estate |
$59,074 |
Security Purchase Plan
|
27 Feb 2025 8:43AM |
$32.150 |
$28.890 |
fallen by
10.14%
|
|
| Mad Paws Holdings Limited (MPA) ORDINARY FULLY PAID |
Consumer Discretionary |
- |
1H FY 2025 Results Announcement
|
27 Feb 2025 8:42AM |
$0.079 |
$0.140 |
risen by
77.22%
|
|
MPA - Price-sensitive ASX Announcement
Full Release
Key Points
- Group Operating Revenues of $14.7 million - flat on pcp, and +11% excluding Sash and Waggly
- Marketplace Operating Revenue of $4.8 million – up 12% on pcp
- E-Commerce Revenue of $9.9 million – down 5% on pcp, +11% excluding Sash and Waggly
- Achieved Group Cash EBITDA positive for 1H FY25 of $0.3 million +172% on pcp
- Segment Operating EBITDA positive at $2.2 million, +76% on pcp
- Marketplace Cash EBITDA of $2.2 million up from $1.7 million in the pcp, with an EBITDA margin of 45.8%
- Ecommerce & Subscription Cash EBITDA break-even for 1H FY25, +$0.5 million on pcp
- Strong momentum across core businesses with $1.9 million remaining in SWM media contra
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Novatti Group Limited (NOV) ORDINARY FULLY PAID |
Information Technology |
$16 |
Appendix 4D Half Year Report and Accounts
|
27 Feb 2025 8:41AM |
$0.032 |
$0.027 |
fallen by
15.63%
|
|
NOV - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue increased by 22.3% to $26.2 million.
- Loss after tax attributable to owners decreased to $2.02 million.
- Significant gains from discontinued operations amounting to $3.02 million.
- Ongoing strategic efforts to streamline operations and focus on higher-margin services.
- Successful capital raise of $7 million to fund growth initiatives.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Truscreen Group Limited (TRU) ORDINARY FULLY PAID FOREIGN EXEMPT NZX |
Health Care |
$11 |
TruScreen Signs MOU with Hangzhou Dalton Bioscience
|
27 Feb 2025 8:41AM |
$0.028 |
$0.015 |
fallen by
46.43%
|
|
TRU - Price-sensitive ASX Announcement
Full Release
Key Points
- TruScreen signed a non-binding MOU with Hangzhou Dalton Bioscience.
- The MOU aims to expand TruScreen's HPV related product portfolio.
- Collaboration will enhance access to cervical cancer screening solutions.
- TruScreen plans to negotiate a formal distribution agreement within three months.
- The collaboration consists of a short-term and medium-to-long-term phase.
- TruScreen's CEO emphasized the partnership's significance for global healthcare solutions.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Mad Paws Holdings Limited (MPA) ORDINARY FULLY PAID |
Consumer Discretionary |
- |
Appendix 4D and Half Year Report FY 2025
|
27 Feb 2025 8:41AM |
$0.079 |
$0.140 |
risen by
77.22%
|
|
MPA - Price-sensitive ASX Announcement
Full Release
Key Points
- Total revenue increased by 0.6% to $14,767,884.
- Loss after tax increased by 78.9% to $3,871,571.
- Group Cash EBITDA improved by $0.7 million compared to the previous year.
- Successful media campaign launched in partnership with Seven West Media.
- Marketplace division saw a 12% increase in operating revenue.
- e-Commerce division achieved EBITDA break-even for the first time.
- No dividends were paid, recommended, or declared during the period.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| identitii Limited (ID8) ORDINARY FULLY PAID |
Information Technology |
$4 |
Notice of General Meeting/Proxy Form
|
27 Feb 2025 8:41AM |
$0.012 |
$0.005 |
fallen by
58.33%
|
|
| Future Generation Global Limited (FGG) ORDINARY FULLY PAID |
Financials |
$604 |
Appendix 4G
|
27 Feb 2025 8:40AM |
$1.470 |
$1.508 |
risen by
2.55%
|
|
| Red Hawk Mining Limited (RHK) ORDINARY FULLY PAID |
Materials |
- |
Change in substantial holding from FMG
|
27 Feb 2025 8:40AM |
$1.200 |
$1.200 |
fallen by
0%
|
|
| Fortescue Ltd (FMG) ORDINARY FULLY PAID |
Materials |
$65,366 |
Change in substantial holding for RHK
|
27 Feb 2025 8:40AM |
$16.860 |
$21.230 |
risen by
25.92%
|
|
| Mesoblast Limited (MSB) ORDINARY FULLY PAID |
Health Care |
$2,877 |
Corporate Presentation and Half Year Financial Results
|
27 Feb 2025 8:40AM |
$2.460 |
$2.230 |
fallen by
9.35%
|
|
MSB - Price-sensitive ASX Announcement
Full Release
Key Points
- Mesoblast is committed to innovative cellular medicines for serious inflammatory illnesses.
- The company is a leader in allogeneic cellular medicines with facilities in Australia, the U.S., and Singapore.
- RYONCIL is the first FDA-approved cell therapy for pediatric patients with SR-aGvHD.
- REVASCOR received multiple designations from the FDA for hypoplastic left heart syndrome.
- Mesoblast anticipates significant advancements in its product pipeline over the next six to twelve months.
- The company has a strong intellectual property portfolio with over 1,100 patents and applications.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Coles Group Limited (COL) ORDINARY FULLY PAID |
Consumer Staple |
$29,071 |
Coles Chair Succession
|
27 Feb 2025 8:39AM |
$19.690 |
$21.660 |
risen by
10.01%
|
|
| Antilles Gold Limited (AAU) ORDINARY FULLY PAID |
Materials |
$37 |
Application for quotation of securities - AAU
|
27 Feb 2025 8:37AM |
$0.005 |
$0.012 |
risen by
140%
|
|
| Mesoblast Limited (MSB) ORDINARY FULLY PAID |
Health Care |
$2,877 |
Half Year Report and Accounts (including Appendix 4D)
|
27 Feb 2025 8:37AM |
$2.460 |
$2.230 |
fallen by
9.35%
|
|
MSB - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue decreased by 7% to $3.156 million.
- Net loss attributable to members increased by 47% to $47.934 million.
- Total cash reserves as of December 31, 2024, were $38 million.
- A global private placement raised $161 million in January 2025.
- The company focuses on commercializing Ryoncil for pediatric patients.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Pantoro Gold Limited (PNR) ORDINARY FULLY PAID |
Materials |
$1,758 |
Wide, high grade gold zones confirmed at Scotia
|
27 Feb 2025 8:37AM |
$0.135 |
$4.460 |
risen by
3,203.70%
|
|
PNR - Price-sensitive ASX Announcement
Full Release
Key Points
- Wide high-grade gold zones confirmed at Scotia.
- 83 grade control holes completed at the Scotia orebody.
- Multiple zones of high-grade gold mineralization identified.
- Potential for expansion of the mine plan indicated.
- Development in first three levels confirmed mineralization outside the current Ore Reserve.
- Transitioning Scotia to a production-focused mine.
- Steady-state operations targeted by the end of March 2025.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Orcoda Limited (ODA) ORDINARY FULLY PAID |
Information Technology |
$13 |
1H FY25 Results Presentation
|
27 Feb 2025 8:36AM |
$0.071 |
$0.068 |
fallen by
4.23%
|
|
ODA - Price-sensitive ASX Announcement
Full Release
Key Points
- Transport SaaS revenue increased by 56% compared to 1H FY24.
- Total income for 1H FY25 was $9.5 million, down 34% from 1H FY24.
- EBITDA was $(0.5) million, a decline from $1.5 million in the previous year.
- Net profit after tax was $(1.5) million.
- The Infrastructure Services division saw a 53% drop in revenue.
- Orcoda is focusing on customer diversification and expanding SaaS capabilities.
- Cost management strategies included redundancies and controlled expenditures.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| BPH Global Ltd (BP8) ORDINARY FULLY PAID |
Health Care |
$6 |
Section 708A Notice
|
27 Feb 2025 8:36AM |
$0.004 |
$0.003 |
fallen by
25%
|
|
| Orcoda Limited (ODA) ORDINARY FULLY PAID |
Information Technology |
$13 |
1H FY25 Results Summary
|
27 Feb 2025 8:35AM |
$0.071 |
$0.068 |
fallen by
4.23%
|
|
ODA - Price-sensitive ASX Announcement
Full Release
Key Points
- 1H FY25 total income was $9.5 million, down 34% year-on-year.
- Transport Technology division saw SaaS revenue growth of 56% compared to the previous period.
- Annual Recurring Revenue (ARR) at $4.5 million, an 11% increase.
- Betta Group's revenue declined due to largest customer deferring works program.
- The company recorded positive net operating cash flows each quarter.
- Orcoda ended the half with cash and cash equivalents of $3.1 million.
- Outlook remains positive with expectations for continued growth in Transport Technology.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Call 1300 880 160
Start a chat
Schedule a call
